David J. Chaplin
Impact in
- Cancer Research top 0.5%
- Cancer, Hypoxia, and Metabolism
- Oncology top 2%
- Cancer Treatment and Pharmacology
Papers in
-
- Cancer, Hypoxia, and Metabolism 53
- Oncology 36
- Cancer Treatment and Pharmacology 8
- Co-authors
- Michael R. Horsman (30 shared papers)Peggy L. Olive (8 shared papers)Dietmar W. Siemann (14 shared papers)Sally A. Hill (14 shared papers)Ralph E. Durand (4 shared papers)Gillian M. Tozer (12 shared papers)George R. Pettit (9 shared papers)Scott L. Young (2 shared papers)
- Journals
- International Journal of Radiation Oncology*Biology*Physics (23 papers)Radiotherapy and Oncology (10 papers)British Journal of Cancer (7 papers)International Journal of Cancer (6 papers)Bioorganic & Medicinal Chemistry Letters (6 papers)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
David J. Chaplin
161 papers receiving 8.3k citations
Peers
Comparison fields: 5 of 129
- Cancer Research 2.6k
- Oncology 1.6k
- Biotechnology 556
- Radiology, Nuclear Medicine and Imaging 1.1k
- Toxicology 174
Countries citing papers authored by David J. Chaplin
This map shows the geographic impact of David J. Chaplin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Chaplin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Chaplin more than expected).
Fields of papers citing papers by David J. Chaplin
This network shows the impact of papers produced by David J. Chaplin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Chaplin. The network helps show where David J. Chaplin may publish in the future.
Co-authors
The 25 scholars most cited alongside David J. Chaplin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 164 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 472 | |
| 2 | Intermittent blood flow in a murine tumor: radiobiological effects. | 1987 | 396 |
| 3 | Combretastatin A-4 phosphate as a tumor vascular-targeting agent: early effects in tumors and normal tissues. | 1999 | 305 |
| 4 | 2004 | 270 | |
| 5 | 2003 | 265 | |
| 6 | Mechanisms associated with tumor vascular shut-down induced by combretastatin A-4 phosphate: intravital microscopy and measurement of vascular permeability. | 2001 | 256 |
| 7 | 1986 | 239 | |
| 8 | Anti-vascular approaches to solid tumour therapy: evaluation of combretastatin A4 phosphate. | 1999 | 234 |
| 9 | 2009 | 227 | |
| 10 | 2004 | 179 | |
| 11 | Targeting gene therapy to cancer: a review. | 1997 | 171 |
| 12 | 1989 | 157 | |
| 13 | 1993 | 156 | |
| 14 | Effects of combretastatin A4 phosphate on endothelial cell morphology in vitro and relationship to tumour vascular targeting activity in vivo. | 2001 | 155 |
| 15 | 2011 | 147 | |
| 16 | Induction of apoptosis in proliferating human endothelial cells by the tumor-specific antiangiogenesis agent combretastatin A-4. | 1998 | 136 |
| 17 | 1987 | 135 | |
| 18 | 2010 | 122 | |
| 19 | The first international conference on vascular targeting: meeting overview. | 2003 | 121 |
| 20 | Tumor radiosensitization by nicotinamide: a result of improved perfusion and oxygenation. | 1989 | 117 |
About David J. Chaplin
David J. Chaplin is a scholar working on Cancer Research, Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Organic Chemistry, having authored 164 papers that have together received 8.6k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (53 papers), Angiogenesis and VEGF in Cancer (37 papers), Synthesis and biological activity (18 papers), Radiation Therapy and Dosimetry (10 papers), Click Chemistry and Applications (10 papers), Nanoplatforms for cancer theranostics (10 papers), Effects of Radiation Exposure (9 papers) and Cancer Treatment and Pharmacology (8 papers). The work is most often cited by research in Cancer Research (2.6k citations), Oncology (1.6k citations), Biotechnology (556 citations), Radiology, Nuclear Medicine and Imaging (1.1k citations) and Toxicology (174 citations). David J. Chaplin has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Michael R. Horsman, Peggy L. Olive, Dietmar W. Siemann, Sally A. Hill, Ralph E. Durand, Gillian M. Tozer, George R. Pettit, Scott L. Young, Borivoj Vojnovic and M.R.L. Stratford. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Radiotherapy and Oncology, British Journal of Cancer, International Journal of Cancer and Bioorganic & Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.